Recent analyses reveal a rapidly evolving landscape for the Rivaroxaban market, expected to experience significant shifts in market share by 2035. With a market size projected to grow from USD 8.16 billion in 2024 to USD 16.01 billion in 2035, the competitive dynamics are intensifying. The compound annual growth rate (CAGR) of 6.32% further underscores the escalating demand for Rivaroxaban as a...